Patents by Inventor Eva-Maria TANZER

Eva-Maria TANZER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20220306588
    Abstract: The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 29, 2022
    Applicant: Merck Patent GmbH
    Inventors: Eva-Maria TANZER, Kai SCHIEMANN, Markus KLEIN
  • Benzimidazole derivatives as adenosine receptor antagonists
    Patent number: 11453647
    Abstract: The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: September 27, 2022
    Assignee: Merck Patent GmbH
    Inventors: Eva-Maria Tanzer, Kai Schiemann, Markus Klein
  • THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20220119412
    Abstract: The invention relates to thiazolopyridine derivatives which fall under the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Application
    Filed: January 21, 2020
    Publication date: April 21, 2022
    Applicant: Merck Patent GmbH
    Inventors: Eva-Maria TANZER, Kai SCHIEMANN, Alejandro CRESPO
  • Quinoxaline derivatives as adenosine receptor antagonists
    Patent number: 11192899
    Abstract: The invention relates to quinoxaline derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: December 7, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Eva-Maria Tanzer, Kai Schiemann, Markus Klein
  • Thiazolopyridine derivatives as adenosine receptor antagonists
    Patent number: 11186592
    Abstract: The invention relates to thiazolopyridine derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: November 30, 2021
    Assignee: Merck Patent GmbH
    Inventors: Eva-Maria Tanzer, Kai Schiemann, Markus Klein
  • QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20200354375
    Abstract: The invention relates to quinoxaline derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Application
    Filed: August 20, 2018
    Publication date: November 12, 2020
    Applicant: MERCK PATENT GMBH
    Inventors: Eva-Maria TANZER, Kai SCHIEMANN, Markus KLEIN
  • BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20200207720
    Abstract: The invention relates to benzimidazole derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Application
    Filed: August 20, 2018
    Publication date: July 2, 2020
    Applicant: Merck Patent GmbH
    Inventors: Eva-Maria TANZER, Kai SCHIEMANN, Markus KLEIN
  • THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20200181171
    Abstract: The invention relates to thiazolopyridine derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Application
    Filed: July 2, 2018
    Publication date: June 11, 2020
    Applicant: MERCK PATENT GMBH
    Inventors: Eva-Maria TANZER, Kai SCHIEMANN, Markus KLEIN